[Clinical trial of UCB 630].
D000328:Adult; D000994:Antitrichomonal Agents / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use*; D009761:Nystatin / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D012828:Silicones; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D014848:Vulvovaginitis / Q000188:drug therapy
D000994:Antitrichomonal Agents; D001152:Arsenicals; D004338:Drug Combinations; D011113:Polymyxins; D012828:Silicones; D009761:Nystatin; C006119:acetarsol, dimethicone, neomycin, nystatin, polymyxin drug combination; D009355:Neomycin
Experimentation clinique de l'UCB 630